MedTrace Logo

Validation of a Score of Predictive Factors for Complete Resection in Platinum-sensitive Recurrent Ovarian Cancer

NCT00368420 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 122

Last updated 2011-02-15

No results posted yet for this study

Summary

The purpose of this study is to validate a score developed by the AGO-OVAR for complete resection of the tumor

Conditions

Sponsors & Collaborators

  • Arbeitsgemeinschaft Gynaekologische Onkologie Austria

    collaborator OTHER

  • MITO

    collaborator UNKNOWN

  • AGO Study Group

    lead OTHER

Principal Investigators

  • Philipp Harter, Dr. · Dr. Horst Schmidt Klinik Wiesbaden

  • Annette Hasenburg, PD Dr. · Universitäts-Frauenklinik Freiburg

  • Andreas du Bois, Prof. Dr. · Dr. Horst Schmidt Klinik Wiesbaden

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-09-30
Primary Completion
2008-07-31
Completion
2009-10-31

Countries

  • Austria
  • Belgium
  • Germany
  • Italy

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00368420 on ClinicalTrials.gov